Sign Up for a Free Account

This is an image preview.
Start a Free Account
to view the full image.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Glucosylsphingosine levels at diagnosis of Gaucher disease

Classification of mild type 1, severe type 1, and neuronopathic Gaucher disease (nGD) was based on genotypes. Glucosylsphingosine (lyso-Gb1) levels of subjects with wild-type GBA1 were considered to be the control.

Abbreviations: lyso-Gb1, glucosylsphingosine; nGD, neuronopathic Gaucher disease; NS, non-significant. Black dots represent the outliers.

(Source: Dinur T, Bauer P, Beetz C, et al. Gaucher disease diagnosis using Lyso-Gb1 on dry blood spot samples: time to change the paradigm? Int J Mol Sci 2022;23[3]:1627. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org/licenses/by/4.0.)